The second session consisted of a round table, where four experts spoke about the promises and realities of personalised precision medicine. With Silvia Fornós, journalist of Diari de Tarragona as moderator, Dr. Núria Amigó (Co-founder and CEO of the spin-off Biosfer Teslab S.L), Dr. Elisabet Vilella (Head of the research group GAP – Genetics and Environment in Psychiatry), Dr. Josep M del Bas (Director of the Nutrition and Health Unit -Eurecat) and Dr. Josep Basora i Gallisà (Director of IDIAP Jordi Gol) debated for more than an hour about the advantages and realities of precision personalised medicine and how to implement them in the research areas of the IISPV.